Last reviewed · How we verify
Intra-articular corticosteroid injections (intra-articular-corticosteroid-injections)
Intra-articular corticosteroid injections (generic name: intra-articular-corticosteroid-injections) is a Corticosteroid drug developed by Pfizer. It is currently FDA-approved for Osteoarthritis of the knee, Osteoarthritis of the hip, Rheumatoid arthritis.
Intra-articular corticosteroid injections are used to treat conditions such as Plantar Fasciopathy and Chronic Pain, as indicated by ClinicalTrials.gov. The mechanism of action of corticosteroids involves blocking the voltage-dependent N-type calcium channel subunit alpha-1B, as per ChEMBL.
At a glance
| Generic name | intra-articular-corticosteroid-injections |
|---|---|
| Sponsor | Pfizer |
| Drug class | Corticosteroid |
| Target | Glucocorticoid receptor |
| Therapeutic area | Immunology |
| Phase | FDA-approved |
Approved indications
- Osteoarthritis of the knee
- Osteoarthritis of the hip
- Rheumatoid arthritis
- Tendinitis (e.g., Achilles, rotator cuff)
- Bursitis (e.g., olecranon, prepatellar)
- Synovitis (e.g., of the knee, elbow)
- Epicondylitis (e.g., tennis elbow)
- Trigger finger
- Gouty arthritis
- Psoriatic arthritis
- Ankylosing spondylitis
- Polymyalgia rheumatica
- Frozen shoulder
- Tendinosis (e.g., patellar)
Common side effects
- Arthralgia
- Headache
- Viral upper respiratory tract infection
- Injection site pain
- Toothache
- Upper respiratory tract infection
- Joint swelling
- Spinal pain
- Pyrexia
- Bronchitis
- Abdominal Pain Upper
- Diarrhea
Drug interactions
- Aspirin
- Anticoagulants
- Antibiotics
- Antifungals
- Cyclosporine
- Methotrexate
- Nonsteroidal anti-inflammatory drugs (NSAIDs)
- Warfarin
- Live vaccines
- Typhoid vaccine
Key clinical trials
- OMT for Adhesive Capsulitis (PHASE4)
- Capsular Distension Versus Corticosteroid Injection in Adhesive Capsulitis (NA)
- Evolution of Post-Stroke Shoulder Pain With a Capsular Pattern With Physiotherapy Alone Versus Coupled With Mild Arthrographic Distension With Cortisone (PHASE4)
- Corticosteroid Meniscectomy Randomized Trial (PHASE4)
- Knee Injections for Obese Patients With Knee Arthritis (PHASE4)
- A Study to Determine the Safety and Effectiveness of a Connective Tissue Allograft (ActiveMatrix) Verses Standard of Care in Adhesive Capsulitis of the Shoulder (PHASE4)
- This is a Study to Verify if Periarticular Hip Injection of Corticosteroid After Hip Replacement Reduce the Pain and the Hospitalisation Time (PHASE4)
- Ultrasound-Guided Intra-Articular vs Gluteal Intramuscular Corticosteroid Injection for Frozen Shoulder (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Intra-articular corticosteroid injections CI brief — competitive landscape report
- Intra-articular corticosteroid injections updates RSS · CI watch RSS
- Pfizer portfolio CI
Frequently asked questions about Intra-articular corticosteroid injections
What is Intra-articular corticosteroid injections?
Intra-articular corticosteroid injections (intra-articular-corticosteroid-injections) is a Corticosteroid drug developed by Pfizer, indicated for Osteoarthritis of the knee, Osteoarthritis of the hip, Rheumatoid arthritis.
What is Intra-articular corticosteroid injections used for?
Intra-articular corticosteroid injections is indicated for Osteoarthritis of the knee, Osteoarthritis of the hip, Rheumatoid arthritis, Tendinitis (e.g., Achilles, rotator cuff), Bursitis (e.g., olecranon, prepatellar).
Who makes Intra-articular corticosteroid injections?
Intra-articular corticosteroid injections is developed and marketed by Pfizer (see full Pfizer pipeline at /company/pfizer).
What is the generic name of Intra-articular corticosteroid injections?
intra-articular-corticosteroid-injections is the generic (nonproprietary) name of Intra-articular corticosteroid injections.
What drug class is Intra-articular corticosteroid injections in?
Intra-articular corticosteroid injections belongs to the Corticosteroid class. See all Corticosteroid drugs at /class/corticosteroid.
What development phase is Intra-articular corticosteroid injections in?
Intra-articular corticosteroid injections is FDA-approved (marketed).
What are the side effects of Intra-articular corticosteroid injections?
Common side effects of Intra-articular corticosteroid injections include Arthralgia, Headache, Viral upper respiratory tract infection, Injection site pain, Toothache, Upper respiratory tract infection.
What does Intra-articular corticosteroid injections target?
Intra-articular corticosteroid injections targets Glucocorticoid receptor and is a Corticosteroid.
Related
- Drug class: All Corticosteroid drugs
- Target: All drugs targeting Glucocorticoid receptor
- Manufacturer: Pfizer — full pipeline
- Therapeutic area: All drugs in Immunology
- Indication: Drugs for Osteoarthritis of the knee
- Indication: Drugs for Osteoarthritis of the hip
- Indication: Drugs for Rheumatoid arthritis
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing